Compare StocksCME vs NVDA

CME Group Inc. (CME) vs NVIDIA Corporation (NVDA): Which Is the Better Buy in 2026?

As of 2026-06-19, CME is overvalued at $246, with a DCF intrinsic value of $218 and a margin of safety of -13%. NVDA is overvalued at $211, with an intrinsic value of $163 and a margin of safety of -29%. Of the two, CME has the wider margin of safety.

CME
CME Group Inc.
$246.38
VS
NVDA
NVIDIA Corporation
$210.69

Rewards

CME
  • Gross margin of 100.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • CME Group Inc. scores 77/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Free cash flow has grown at a 12.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
NVDA
  • NVIDIA Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 74.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 193.9% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

CME
  • PEG ratio of 4.59 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.53 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
NVDA
  • FCF yield of 1.9% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Beneish M-Score of -1.06 flags financial patterns consistent with potential earnings manipulation — warrants further investigation.
  • 39 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
CME
NVDA
Valuation
$4.19B
Free Cash Flow
$96.68B
4.71%
FCF Yield
1.89%
21.41
Trailing P/E
32.26
19.07
Forward P/E
16.55
Quality & Moat
12.25%
ROIC
63.06%
15.92%
ROE
114.29%
100.00%
Gross Margin
74.14%
4.59
PEG Ratio
0.64
Balance Sheet Safety
0.05
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
0.26
Net Debt / EBITDA
-0.24
1.99%
Dividend Yield
0.02%
CME: 4Ties: 1NVDA: 7
CMENVDA

Historical Fundamentals

Learn more →
CME

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

NVDA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
CME
$526.78
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$71.5M
Δ Market Cap
+$37.66B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
NVDA
$17.68
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$220.50B
Δ Market Cap
+$3.90T
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CME
12.9% Overvalued
Price is 12.9% above estimated fair value
Current Price: $246.38
Fair Value: $218.17
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
NVDA
44.3% Margin of Safety
Price is 44.3% below estimated fair value
Current Price: $210.69
Fair Value: $378.18
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CME

What growth rate is the market pricing in at $246?

+8.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +8.3% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +8.7%, reflecting heavy growth investment expected to generate future returns.

NVDA

What growth rate is the market pricing in at $211?

+17.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +20.8%

The market implies +17.9% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +20.8%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
CME
77/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by margin stability. ROIC Consistency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
NVDA
69/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with roic consistency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
CME
-2.43
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
NVDA
-1.06
Likely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CME
Insiders 0.4%Institutions 92.7%Retail & Other 6.9%
No. of Institutional Holders2,391
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
NVDA
Insiders 4.0%Institutions 70.9%Retail & Other 25.1%
No. of Institutional Holders7,556
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CME
1
Buys (3M)
2
Buys (12M)
Total value (12M): $509,437
SHEPARD WILLIAM R
Director
$437,101
@ $297.55 · 2026-03-26
SHEPARD WILLIAM R
Director
$72,336
@ $270.92 · 2025-06-25
SHEPARD WILLIAM R
Director
$71,995
@ $262.76 · 2025-03-26
SHEPARD WILLIAM R
Director
$325,798
@ $227.99 · 2025-01-16
SHEPARD WILLIAM R
Director
$324,198
@ $227.99 · 2025-01-16
BENESH KATHRYN
Director
$3,595
@ $239.67 · 2024-12-27
SHEPARD WILLIAM R
Director
$63,945
@ $218.99 · 2024-09-25
Open market purchases · includes direct & indirect ownership · excludes option exercises
NVDA
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CME
2
Sells (3M)
14
Sells (12M)
Total value (12M): $28.07M
PIELL HILDA HARRIS
Officer
$1.75M
@ $304.63 · 2026-05-18
DUFFY TERRENCE A
Chief Executive Officer
$10.45M
@ $298.51 · 2026-05-15
MARCUS JONATHAN L
General Counsel
$1.10M
@ $333.37 · 2026-03-17
MARCUS JONATHAN L
Officer
$1.03M
@ $313.37 · 2026-03-17
VROMAN KENDAL L
Officer
$1.59M
@ $309.00 · 2026-03-12
DURKIN BRYAN T
Director
$1.30M
@ $309.65 · 2026-02-23
GEPSMAN MARTIN J
Director
$91,770
@ $305.90 · 2026-02-20
SUSKIND DENNIS A
Director
$224,400
@ $300.00 · 2026-02-06
DUFFY TERRENCE A
Chief Executive Officer
$6.74M
@ $269.55 · 2025-12-11
FORD HAROLD EUGENE JR
Director
$263,530
@ $263.53 · 2025-11-03
MARCUS JONATHAN L
General Counsel
$102,704
@ $262.00 · 2025-09-18
MCCOURT TIMOTHY FRANCIS
Officer
$98,476
@ $259.83 · 2025-09-16
MARCUS JONATHAN L
General Counsel
$97,369
@ $258.96 · 2025-09-16
CUTINHO SUNIL KIRAN
Chief Technology Officer
$3.23M
@ $271.47 · 2025-08-26
KAYE DANIEL G
Director
$141,210
@ $282.42 · 2025-05-22
MARCUS JONATHAN L
General Counsel
$108,225
@ $277.50 · 2025-05-20
LOCKETT PHYLLIS M
Director
$294,553
@ $277.88 · 2025-05-19
GEPSMAN MARTIN J
Director
$81,951
@ $273.17 · 2025-05-15
SUSKIND DENNIS A
Director
$271,280
@ $271.28 · 2025-04-29
GERDES LARRY G
Director
$1.06M
@ $265.11 · 2025-04-25
LUCAS DEBORAH J
Director
$385,425
@ $256.95 · 2025-03-14
DUFFY TERRENCE A
Chief Executive Officer
$7.78M
@ $259.18 · 2025-03-11
SPRAGUE SUZANNE
Chief Operating Officer
$385,249
@ $256.83 · 2025-03-03
PIELL HILDA HARRIS
Officer
$997,853
@ $250.47 · 2025-02-27
WINKLER JULIE
Officer
$2.89M
@ $249.17 · 2025-02-13
VROMAN KENDAL L
Officer
$1.27M
@ $250.00 · 2025-02-13
GEPSMAN MARTIN J
Director
$89,168
@ $222.92 · 2024-11-04
CUTINHO SUNIL KIRAN
Chief Technology Officer
$1.02M
@ $226.64 · 2024-10-30
BITSBERGER TIMOTHY S
Director
$226,957
@ $226.96 · 2024-10-30
MCCOURT TIMOTHY FRANCIS
Officer
$312,056
@ $227.11 · 2024-10-28
FITZPATRICK LYNNE
Chief Financial Officer
$163,610
@ $216.99 · 2024-09-13
DURKIN BRYAN T
Director
$1.63M
@ $214.59 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
NVDA
1
Sells (3M)
39
Sells (12M)
Total value (12M): $1.09B
DABIRI JOHN O
Director
$133,750
@ $214.00 · 2026-05-27
ROBERTSON DONALD F JR
Officer
$942,944
@ $174.75 · 2026-03-20
SHAH AARTI S
Director
$3.36M
@ $176.71 · 2026-03-19
DABIRI JOHN O
Director
$555,440
@ $184.90 · 2026-03-13
ROBERTSON DONALD F JR
Officer
$15.19M
@ $189.85 · 2026-01-02
ROBERTSON DONALD F JR
Officer
$4.43M
@ $179.98 · 2025-12-19
DABIRI JOHN O
Director
$112,317
@ $179.42 · 2025-11-24
HUANG JEN-HSUN
Chief Executive Officer
$5.20M
@ $207.91 · 2025-10-29
HUANG JEN-HSUN
Chief Executive Officer
$23.56M
@ $188.47 · 2025-10-28
HUANG JEN-HSUN
Chief Executive Officer
$40.73M
@ $181.04 · 2025-10-23
HUANG JEN-HSUN
Chief Executive Officer
$41.06M
@ $182.48 · 2025-10-20
HUANG JEN-HSUN
Chief Executive Officer
$41.34M
@ $183.73 · 2025-10-15
HUANG JEN-HSUN
Chief Executive Officer
$42.89M
@ $190.60 · 2025-10-10
HUANG JEN-HSUN
Chief Executive Officer
$42.05M
@ $186.89 · 2025-10-07
HUANG JEN-HSUN
Chief Executive Officer
$42.09M
@ $187.08 · 2025-10-02
HUANG JEN-HSUN
Chief Executive Officer
$40.23M
@ $178.82 · 2025-09-29
HUANG JEN-HSUN
Chief Executive Officer
$40.21M
@ $178.69 · 2025-09-24
HUANG JEN-HSUN
Chief Executive Officer
$39.18M
@ $174.14 · 2025-09-19
ROBERTSON DONALD F JR
Officer
$617,298
@ $176.37 · 2025-09-19
HUANG JEN-HSUN
Chief Executive Officer
$39.75M
@ $176.66 · 2025-09-16
HUANG JEN-HSUN
Chief Executive Officer
$39.28M
@ $174.59 · 2025-09-11
HUANG JEN-HSUN
Chief Executive Officer
$38.01M
@ $168.95 · 2025-09-08
HUANG JEN-HSUN
Chief Executive Officer
$38.61M
@ $171.60 · 2025-09-03
HUDSON BEACH DAWN E
Director
$15.38M
@ $170.90 · 2025-09-03
HUANG JEN-HSUN
Chief Executive Officer
$27.12M
@ $180.79 · 2025-08-15
HUANG JEN-HSUN
Chief Executive Officer
$40.96M
@ $182.04 · 2025-08-13
HUANG JEN-HSUN
Chief Executive Officer
$40.66M
@ $180.70 · 2025-08-08
HUANG JEN-HSUN
Chief Executive Officer
$39.78M
@ $176.80 · 2025-08-05
HUANG JEN-HSUN
Chief Executive Officer
$40.18M
@ $178.58 · 2025-07-31
HUANG JEN-HSUN
Chief Executive Officer
$39.16M
@ $174.02 · 2025-07-28
HUANG JEN-HSUN
Chief Executive Officer
$38.22M
@ $169.87 · 2025-07-23
HUANG JEN-HSUN
Chief Executive Officer
$38.71M
@ $172.05 · 2025-07-18
HUANG JEN-HSUN
Chief Executive Officer
$37.59M
@ $167.08 · 2025-07-15
HUANG JEN-HSUN
Chief Executive Officer
$36.43M
@ $161.91 · 2025-07-10
HUANG JEN-HSUN
Chief Executive Officer
$35.55M
@ $158.02 · 2025-07-07
HUANG JEN-HSUN
Chief Executive Officer
$35.16M
@ $156.27 · 2025-07-01
HUANG JEN-HSUN
Chief Executive Officer
$30.47M
@ $152.33 · 2025-06-26
HUANG JEN-HSUN
Chief Executive Officer
$14.40M
@ $144.04 · 2025-06-23
ROBERTSON DONALD F JR
Officer
$646,469
@ $143.66 · 2025-06-20
BURGESS ROBERT KENNETH
Director
$6.74M
@ $134.82 · 2025-05-30
DABIRI JOHN O
Director
$91,608
@ $138.80 · 2025-05-30
KRESS COLETTE M.
Chief Financial Officer
$7.79M
@ $116.83 · 2025-03-21
ROBERTSON DONALD F JR
Officer
$525,585
@ $116.80 · 2025-03-21
SHAH AARTI S
Director
$2.37M
@ $118.42 · 2025-03-20
BURGESS ROBERT KENNETH
Director
$6.16M
@ $115.49 · 2025-03-13
DABIRI JOHN O
Director
$292,930
@ $110.00 · 2025-03-10
KRESS COLETTE M.
Chief Financial Officer
$9.03M
@ $135.40 · 2024-12-13
ROBERTSON DONALD F JR
Officer
$608,775
@ $135.28 · 2024-12-13
DABIRI JOHN O
Director
$101,672
@ $142.00 · 2024-11-25
KRESS COLETTE M.
Chief Financial Officer
$7.77M
@ $116.59 · 2024-09-20
ROBERTSON DONALD F JR
Officer
$524,293
@ $116.51 · 2024-09-20
HUANG JEN-HSUN
Chief Executive Officer
$28.55M
@ $118.97 · 2024-09-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CME
FearGreed
😨Fear(32/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
NVDA
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CME
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (32)
NVDA
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
View CME Full AnalysisView NVDA Full Analysis

Frequently Asked Questions: CME vs NVDA

Is CME Group Inc. or NVIDIA Corporation more undervalued in 2026?

Based on our discounted cash flow model, CME trades at a -12.9% margin of safety (intrinsic value $218 vs. price $246), compared to NVDA's -29.0% margin of safety (intrinsic $163 vs. $211).

Which stock has a wider economic moat, CME Group Inc. or NVIDIA Corporation?

CME scores 77/100 (Wide moat), while NVDA scores 69/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is CME Group Inc. in financial distress?

CME's Altman Z-Score of 0.5 places it in the Distress zone, signaling elevated bankruptcy risk. NVDA scores 66.7 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, CME Group Inc. or NVIDIA Corporation?

CME Group Inc. (CME) generates a 4.7% free cash flow yield, compared to NVIDIA Corporation's 1.9%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, CME Group Inc. or NVIDIA Corporation?

NVDA earns 63.1% ROIC versus CME's 12.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, CME Group Inc.'s or NVIDIA Corporation's?

NVDA's dividend earns a safety score of 91/100 (Very Safe), compared to CME's 34/100 (Unsafe). NVDA has raised its dividend for 2 consecutive years.

Does NVIDIA Corporation have accounting red flags?

NVDA's Beneish M-Score of -1.1 flags it as a likely earnings manipulator (above the -1.78 threshold). By contrast, CME scores -2.4, within the normal range. The Beneish model detects aggressive accounting through eight financial ratios.